Anjil Giri

Title: Anjil Giri: Innovator in Antibody Production

Introduction

Anjil Giri is a notable inventor based in Hamden, Connecticut. He has made significant contributions to the field of biotechnology, particularly in the production of therapeutic antibodies. His work is instrumental in advancing medical treatments and improving patient outcomes.

Latest Patents

Anjil Giri holds a patent for "Methods of producing anti-C5 antibodies." This patent describes a method for producing an anti-C5 antibody known as ravulizumab. The method involves culturing mammalian cells that contain a nucleic acid encoding the anti-C5 antibody in a specialized cell culture production medium. The process includes multiple purification steps, such as Protein A affinity chromatography, low pH viral inactivation, cation exchange chromatography, anion exchange chromatography, virus reduction filtration, and concentration and diafiltration.

Career Highlights

Anjil Giri is currently employed at Alexion Pharmaceuticals, Inc., where he continues to innovate in the field of antibody production. His expertise and dedication to research have positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Anjil has collaborated with several talented individuals, including Hunter F Malanson and Kyle A Zingaro. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Anjil Giri's work in the production of anti-C5 antibodies exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for advancements in therapeutic treatments, showcasing the importance of dedicated inventors in the medical field.